Bmc Complementary And Alternative Medicine SCIE

国际简称：BMC COMPLEM ALTERN M 参考译名：Bmc 补充和替代医学

主要研究方向：INTEGRATIVE & COMPLEMENTARY MEDICINE 非预警期刊审稿周期：一般,3-6周

《Bmc 补充和替代医学》(Bmc Complementary And Alternative Medicine)是一本由BioMed Central出版的以INTEGRATIVE & COMPLEMENTARY MEDICINE为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
0 年发文量
开放是否OA
72 H-index
2001 创刊年份
Irregular 出版周期
English 出版语言

BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation.

[ 查看全部 ]

投稿咨询加急咨询

Bmc Complementary And Alternative Medicine期刊信息

ISSN：1472-6882
出版语言：English
是否OA：开放
E-ISSN：2662-7671
出版地区：ENGLAND
是否预警：否
出版商：BioMed Central
出版周期：Irregular
创刊时间：2001
开源占比：1
Gold OA文章占比：100.00%
OA被引用占比：
出版国人文章占比：0
出版撤稿占比：
研究类文章占比：0.00%

Bmc Complementary And Alternative Medicine CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

6.1

0.673

1.08

学科类别	分区	排名	百分位
大类：Medicine 小类：Complementary and Alternative Medicine	Q1	18 / 105	83%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Bmc Complementary And Alternative Medicine中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	2区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学	2区

Bmc Complementary And Alternative Medicine JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位

Bmc Complementary And Alternative Medicine历年数据统计

影响因子

中科院分区

Bmc Complementary And Alternative Medicine中国学者发文选摘

1、Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy
Author: Cai, Weiye; Sun, Bin; Song, Chao; Liu, Fei; Wu, Zhengliang; Liu, Zongchao

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03943-8
2、Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
Author: Jiang, Yunzhong; Zhang, Mengzhao; Wang, Lu; Zhang, Lu; Ma, Minghai; Jing, Minxuan; Li, Jianpeng; Song, Rundong; Zhang, Yuanquan; Yang, Zezhong; Zhang, Yaodong; Pu, Yuanchun; Qu, Xiaowei; Fan, Jinhai

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03938-5
3、Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation
Author: Fan, Zhu; Wang, Shuxin; Xu, Chenchen; Yang, Jiao; Cui, Bingnan

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03960-7
4、Panax quinquefolius saponin inhibits vascular smooth muscle cell calcification via activation of nuclear factor-erythroid 2-related factor 2
Author: Lu, Xiaoting; Liu, Xue; Liang, Ershun; Yang, Ruixue; Liu, Yan; Liu, Xiaoqiong; Yan, Fangfang; Xing, Yifan

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03961-6
5、Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells
Author: Huang, Le-Tian; Li, Tie-Jun; Li, Ming-Lin; Luo, Han-Yong; Wang, Yi-Bing; Wang, Jia-He

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-023-03944-7
6、Oxymatrine ameliorates myocardial injury by inhibiting oxidative stress and apoptosis via the Nrf2/HO-1 and JAK/STAT pathways in type 2 diabetic rats
Author: Huang, Yongpan; He, Bin; Song, Chong; Long, Xian; He, Jianbin; Huang, Yansong; Liu, Lijing

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-022-03818-4
7、Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology
Author: Wang, Sutong; Ji, Tianshu; Wang, Lin; Qu, Yiwei; Wang, Xinhui; Wang, Wenting; Lv, Mujie; Wang, Yongcheng; Li, Xiao; Jiang, Ping

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-022-03826-4
8、Costs of traditional Chinese medicine treatment for inpatients with lung cancer in China: a national study
Author: Nie, Hanlin; Han, Zhaoran; Nicholas, Stephen; Maitland, Elizabeth; Huang, Zhengwei; Chen, Sisi; Tuo, Zegui; Ma, Yong; Shi, Xuefeng

Journal: BMC COMPLEMENTARY MEDICINE AND THERAPIES. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12906-022-03819-3